BIIB - Biogen Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
3,046,900
3,046,900
1,556,100
4,000,600
5,888,500
Depreciation & amortisation
518,400
518,400
487,700
457,200
680,600
Deferred income taxes
-168,600
-168,600
-426,800
149,000
67,100
Stock-based compensation
254,100
254,100
238,600
198,300
182,300
Change in working capital
-890,300
-890,300
-145,500
-187,200
199,300
Accounts receivable
-203,400
-203,400
324,800
2,800
68,800
Inventory
-320,200
-320,200
-462,400
-316,300
-19,200
Other working capital
1,141,100
1,384,300
3,345,000
3,678,000
6,409,100
Other non-cash items
335,300
335,300
337,100
119,900
5,500
Net cash provided by operating activities
1,384,300
1,384,300
3,639,900
4,229,800
7,078,600
Cash flows from investing activities
Investments in property, plant and equipment
-243,200
-243,200
-294,900
-551,800
-669,500
Acquisitions, net
0
0
0
-565,500
-1,044,400
Purchases of investments
-3,448,500
-3,448,500
-3,808,700
-6,838,700
-5,252,600
Sales/maturities of investments
3,671,000
3,671,000
3,498,900
7,374,300
6,486,300
Other investing activities
24,400
24,400
12,900
-26,900
27,000
Net cash used for investing activities
1,576,600
1,576,600
-563,700
-608,600
470,500
Cash flows from financing activities
Debt repayment
-1,002,200
-1,002,200
-170,000
-1,500,000
0
Common stock repurchased
-750,000
-750,000
-1,800,000
-6,679,100
-5,868,300
Other financing activities
6,800
6,800
-115,500
-56,400
7,900
Net cash used provided by (used for) financing activities
-1,747,300
-1,747,300
-2,086,200
-5,272,700
-5,860,400
Net change in cash
1,213,600
1,213,600
990,000
-1,651,500
1,688,700
Cash at beginning of period
2,261,400
2,261,400
1,331,200
2,913,700
1,224,600
Cash at end of period
3,419,300
3,419,300
2,261,400
1,331,200
2,913,700
Free cash flow
Operating cash flow
1,384,300
1,384,300
3,639,900
4,229,800
7,078,600
Capital expenditure
-243,200
-243,200
-294,900
-551,800
-669,500
Free cash flow
1,141,100
1,384,300
3,345,000
3,678,000
6,409,100